Lanfear Capital Advisors

Lanfear Capital seeks only investment opportunities in which it can add value beyond the commitment of capital. We take significant interest in helping entrepreneurs and fledgling companies address issues and make progress in creating value. Decades of experience and industry relationships in a broad spectrum of disciplines are leveraged to benefit our teams. Lanfear Capital looks for entrepreneurs and management teams who wish to operate in a dynamic partnership based on the shared interest of building value. Our operating philosophy is anchored in a foundation of capability, integrity, and uncompromising professionalism. We also invest in select venture funds who share our philosophy and approach.

1 past transactions

InteKrin

Debt Financing in 2006
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.